☰

Yongjing Guo, Ph.D. - Publications

Affiliations: 
2002 McGill University, Montreal, QC, Canada 
Area:
Molecular Biology, Oncology
Tree Info Grants Similar researchers PubMed Report error

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2002 Guo Y, Pakneshan P, Gladu J, Slack A, Szyf M, Rabbani SA. Regulation of DNA methylation in human breast cancer. Effect on the urokinase-type plasminogen activator gene production and tumor invasion. The Journal of Biological Chemistry. 277: 41571-9. PMID 12198113 DOI: 10.1074/Jbc.M201864200  0.503
2002 Guo Y, Mazar AP, Lebrun JJ, Rabbani SA. An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer. Cancer Research. 62: 4678-84. PMID 12183425  0.601
2000 Guo Y, Higazi AA, Arakelian A, Sachais BS, Cines D, Goldfarb RH, Jones TR, Kwaan H, Mazar AP, Rabbani SA. A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 14: 1400-10. PMID 10877833 DOI: 10.1096/Fasebj.14.10.1400  0.601
2000 Rabbani SA, Harakidas P, Guo Y, Steinman D, Davidsen SK, Morgan DW. Synthetic inhibitor of matrix metalloproteases decreases tumor growth and metastases in a syngeneic model of rat prostate cancer in vivo. International Journal of Cancer. 87: 276-82. PMID 10861487 DOI: 10.1002/1097-0215(20000715)87:2<276::Aid-Ijc20>3.0.Co;2-L  0.555
Show low-probability matches.